Please assess the completion status of the following clinical trial:

Trial Title: Standardized Vascular Rehabilitation Program to Improve Patient Disease and Quality of Life

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Enrolled in the vascular rehabilitation program at The Heart Hospital Cardiac Rehabilitation Facility.~2. Female or male patients ≥18 years of age.~3. Patient must be accessible for treatment and follow-up.~4. Agrees to wear the activity tracker wrist-worn device~5. Agrees to the follow-up QOL survey schedule~6. Agrees to the follow-up ABI schedule~7. All patients must be able to understand the investigational nature of the study and give written informed consent prior to study entry.~Exclusion Criteria:~1. Declines participation in the study.~2. Has a life-expectancy less than 18 months.~3. Unable to complete necessary study follow-up procedures.~4. Unwilling to wear the wrist-worn activity tracker device.~5. Women who are pregnant.~6. Patients who have any severe and/or uncontrolled medical conditions or other conditions that could affect their participation such as:~   1. severe impaired lung functions as defined as spirometry and DLCO that is 50% of the normal predicted value and/or O2 saturation that is 88% or less at rest on room air~  2. home oxygen~  3. neurologic or orthopedic conditions limiting ability to appropriately comply with rehabilitation program.~  4. class III or class IV NY class congestive heart failure~7. Concurrent severe, uncontrolled infection or intercurrent illness including, but not limited to, ongoing or active infection, or psychiatric illness/social situations that would limit compliance with study requirements.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Vascular Rehabilitation and Follow Up (Type: OTHER): All subjects will be enrolled in a 6-12 Vascular Rehab Program (VRP) and then be followed for one year following discharge from the VRP.

Based on this trial design, predict the completion outcome and termination type (if applicable).